Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michela Tebaldi

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
International Journal of Colorectal Disease|October 28, 2019
Identification of a novel large EPCAM-MSH2 duplication, concurrently with LOHs in chromosome 20 and X, in a family with Lynch syndromeFrancesca Pirini, Gianluca Tedaldi, Rita Danesi, et al.
International Journal of Cancer|April 21, 2025
Comprehensive genetic and epigenetic characterization of Lynch-like syndrome patientsFrancesca Pirini, Luciano Calzari, Gianluca Tedaldi, et al.
Neoplasia (New York, N.Y.)|July 14, 2017
Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma CellsMara A Bonelli, Graziana Digiacomo, Claudia Fumarola, et al.
Cancers|September 14, 2019
Multigene Panel Testing Increases the Number of Loci Associated with Gastric Cancer PredispositionGianluca Tedaldi, Francesca Pirini, Michela Tebaldi, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 21, 2024
Circulating cell-free and extracellular vesicles-derived microRNA as prognostic biomarkers in patients with early-stage NSCLC: results from RESTING studyElisabetta Petracci, Luigi Pasini, Milena Urbini, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 23, 2026
Vaccine-expanded plasmablast-like B cells are associated with response to dendritic cell therapy in metastatic melanomaMarcella Tazzari, Silvia Carloni, Jenny Bulgarelli, et al.
European Journal of Cancer (Oxford, England : 1990)|July 13, 2024
A randomized phase II trial of Captem or Folfiri as second-line therapy in neuroendocrine carcinomasAlberto Bongiovanni, Chiara Liverani, Flavia Foca, et al.
Leukemia|July 1, 2021
Integrated genomic-metabolic classification of acute myeloid leukemia defines a subgroup with NPM1 and cohesin/DNA damage mutationsGiorgia Simonetti, Carlo Mengucci, Antonella Padella, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
International Journal of Colorectal Disease|October 28, 2019
Identification of a novel large EPCAM-MSH2 duplication, concurrently with LOHs in chromosome 20 and X, in a family with Lynch syndromeFrancesca Pirini, Gianluca Tedaldi, Rita Danesi, et al.
International Journal of Cancer|April 21, 2025
Comprehensive genetic and epigenetic characterization of Lynch-like syndrome patientsFrancesca Pirini, Luciano Calzari, Gianluca Tedaldi, et al.
Neoplasia (New York, N.Y.)|July 14, 2017
Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma CellsMara A Bonelli, Graziana Digiacomo, Claudia Fumarola, et al.
Cancers|September 14, 2019
Multigene Panel Testing Increases the Number of Loci Associated with Gastric Cancer PredispositionGianluca Tedaldi, Francesca Pirini, Michela Tebaldi, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 21, 2024
Circulating cell-free and extracellular vesicles-derived microRNA as prognostic biomarkers in patients with early-stage NSCLC: results from RESTING studyElisabetta Petracci, Luigi Pasini, Milena Urbini, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 23, 2026
Vaccine-expanded plasmablast-like B cells are associated with response to dendritic cell therapy in metastatic melanomaMarcella Tazzari, Silvia Carloni, Jenny Bulgarelli, et al.
European Journal of Cancer (Oxford, England : 1990)|July 13, 2024
A randomized phase II trial of Captem or Folfiri as second-line therapy in neuroendocrine carcinomasAlberto Bongiovanni, Chiara Liverani, Flavia Foca, et al.
Leukemia|July 1, 2021
Integrated genomic-metabolic classification of acute myeloid leukemia defines a subgroup with NPM1 and cohesin/DNA damage mutationsGiorgia Simonetti, Carlo Mengucci, Antonella Padella, et al.
Pageof 3